Tscan Therapeutics Inc

Research Tscan Therapeutics Inc (TCRX) on Bullrun: market cap USD 63.88M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerTCRX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 63.88M
• Financial periodFY2025
• RevenueUSD 10.33M
• Revenue growth266.7%
• Net income-USD 129.77M
• Free cash flow-USD 139.73M

Valuation Snapshot

latest market cap is USD 63.88M.

About Tscan Therapeutics Inc

TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States.

Frequently asked questions

What is Tscan Therapeutics Inc's market cap?

Tscan Therapeutics Inc's market capitalization is USD 63.88M.

What does Tscan Therapeutics Inc do?

TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States.